Detalhe da pesquisa
1.
Cost-Effectiveness Analysis of Abatacept Compared with Adalimumab on Background Methotrexate in Biologic-Naive Adult Patients with Rheumatoid Arthritis and Poor Prognosis.
Value Health
; 21(2): 193-202, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29477401
2.
A cost-effectiveness and budget impact analysis of first-line fidaxomicin for patients with Clostridium difficile infection (CDI) in Germany.
Infection
; 44(5): 599-606, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27062378
3.
Mydriasert pupillary dilation for cataract surgery: an economic and clinical study.
BMC Ophthalmol
; 15: 56, 2015 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26036871
4.
Challenges with Estimating Long-Term Overall Survival in Extensive Stage Small-Cell Lung Cancer: A Validation-Based Case Study.
Clinicoecon Outcomes Res
; 16: 97-109, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38433888
5.
Mifamurtide for high-grade, resectable, nonmetastatic osteosarcoma following surgical resection: a cost-effectiveness analysis.
Value Health
; 16(8): 1123-32, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24326165
6.
A Systematised Literature Review of Real-World Treatment Patterns and Outcomes in Unresectable Advanced or Metastatic Biliary Tract Cancer.
Target Oncol
; 18(6): 837-852, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37751011
7.
Real-world treatment patterns and outcomes in small-cell lung cancer: a systematic literature review.
J Thorac Dis
; 13(6): 3692-3707, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34277061
8.
Evaluating Partitioned Survival and Markov Decision-Analytic Modeling Approaches for Use in Cost-Effectiveness Analysis: Estimating and Comparing Survival Outcomes.
Pharmacoeconomics
; 38(1): 97-108, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31741315
9.
Cost-effectiveness of nivolumab in patients with advanced renal cell carcinoma treated in the United States.
Exp Hematol Oncol
; 7: 4, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29456880
10.
Cost-effectiveness of metformin plus vildagliptin compared with metformin plus sulphonylurea for the treatment of patients with type 2 diabetes mellitus: a Portuguese healthcare system perspective.
J Med Econ
; 17(7): 499-507, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24708176